Marek P. Nowacki

10.0k total citations · 4 hit papers
50 papers, 6.3k citations indexed

About

Marek P. Nowacki is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marek P. Nowacki has authored 50 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 28 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marek P. Nowacki's work include Colorectal Cancer Surgical Treatments (19 papers), Colorectal and Anal Carcinomas (19 papers) and Colorectal Cancer Treatments and Studies (12 papers). Marek P. Nowacki is often cited by papers focused on Colorectal Cancer Surgical Treatments (19 papers), Colorectal and Anal Carcinomas (19 papers) and Colorectal Cancer Treatments and Studies (12 papers). Marek P. Nowacki collaborates with scholars based in Poland, United States and Australia. Marek P. Nowacki's co-authors include Krzysztof Bujko, Ewa Kraszewska, Maciej Rupiński, Marcin Polkowski, E Butruk, Jarosław Reguła, Wojciech Michalski, Anna Nasierowska‐Guttmejer, Mariusz Kryj and Marek Bębenek and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

Marek P. Nowacki

50 papers receiving 6.1k citations

Hit Papers

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin A... 2006 2026 2012 2019 2011 2010 2006 2006 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
    2011 1.4k citations Eric Van Cutsem, Claus-Henning Köhne et al. Journal of Clinical Oncology profile →
  2. Quality Indicators for Colonoscopy and the Risk of Interval Cancer
    2010 1.4k citations Michał F. Kamiński, Jarosław Reguła et al. New England Journal of Medicine profile →
  3. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
    2006 810 citations Krzysztof Bujko, Marek P. Nowacki et al. profile →
  4. Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia
    2006 579 citations Jarosław Reguła, Maciej Rupiński et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek P. Nowacki Poland 25 5.7k 2.7k 2.7k 1.2k 507 50 6.3k
Jean‐François Seitz France 38 4.2k 0.7× 2.8k 1.0× 2.1k 0.8× 582 0.5× 434 0.9× 130 5.9k
Jorge Aparicio Spain 29 3.0k 0.5× 1.7k 0.6× 1.4k 0.5× 667 0.6× 639 1.3× 147 4.3k
Arnaud Roth Switzerland 34 3.4k 0.6× 1.3k 0.5× 1.8k 0.7× 1.4k 1.2× 661 1.3× 115 5.1k
Yong Sang Hong South Korea 33 3.5k 0.6× 1.9k 0.7× 1.3k 0.5× 618 0.5× 395 0.8× 208 4.8k
R.D. James United Kingdom 27 2.9k 0.5× 2.2k 0.8× 1.6k 0.6× 617 0.5× 484 1.0× 58 4.5k
Florin Sirzén Sweden 18 3.6k 0.6× 1.1k 0.4× 2.6k 1.0× 570 0.5× 1.1k 2.1× 28 5.5k
J. Załuski Poland 13 3.7k 0.7× 816 0.3× 1.7k 0.6× 929 0.8× 855 1.7× 23 4.5k
Cynthia G. Leichman United States 30 4.6k 0.8× 1.7k 0.7× 2.0k 0.8× 1.2k 1.0× 611 1.2× 64 6.2k
Woo Yong Lee South Korea 41 3.4k 0.6× 1.9k 0.7× 1.1k 0.4× 754 0.6× 384 0.8× 231 5.0k
Gérard Lledo France 27 5.8k 1.0× 1.7k 0.6× 2.3k 0.9× 712 0.6× 1.6k 3.2× 101 6.5k

Countries citing papers authored by Marek P. Nowacki

Since Specialization
Citations

This map shows the geographic impact of Marek P. Nowacki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek P. Nowacki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek P. Nowacki more than expected).

Fields of papers citing papers by Marek P. Nowacki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek P. Nowacki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek P. Nowacki. The network helps show where Marek P. Nowacki may publish in the future.

Co-authorship network of co-authors of Marek P. Nowacki

This figure shows the co-authorship network connecting the top 25 collaborators of Marek P. Nowacki. A scholar is included among the top collaborators of Marek P. Nowacki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek P. Nowacki. Marek P. Nowacki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rocha‐Lima, Caio, Soley Bayraktar, Charles Weissman, et al.. (2014). A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan. Cancer Chemotherapy and Pharmacology. 74(3). 479–486. 13 indexed citations
2.
Cutsem, Eric Van, Claus-Henning Köhne, István Láng, et al.. (2011). Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status. Journal of Clinical Oncology. 29(15). 2011–2019. 1441 indexed citations breakdown →
3.
Rutkowski, Andrzej, Maciej Chwaliński, Leszek Zając, Zbigniew Nowecki, & Marek P. Nowacki. (2011). Risk of Permanent Stoma After Resection of Rectal Cancer Depending on the Distance Between the Tumour Lower Edge and Anal Verge. Polish Journal of Surgery. 83(11). 588–96. 2 indexed citations
4.
Rutkowski, Andrzej, Marek P. Nowacki, Maciej Chwaliński, et al.. (2010). Acceptance of a 5‐mm distal bowel resection margin for rectal cancer: is it safe?. Colorectal Disease. 14(1). 71–78. 32 indexed citations
5.
Kamiński, Michał F., Jarosław Reguła, Ewa Kraszewska, et al.. (2010). Quality Indicators for Colonoscopy and the Risk of Interval Cancer. New England Journal of Medicine. 362(19). 1795–1803. 1430 indexed citations breakdown →
6.
Tysarowski, Andrzej, Anna Fabisiewicz, Jolanta Kupryjańczyk, et al.. (2008). Validation of selected molecular methods for the mutations determination in codons 12 and 13 of K-RAS gene in five Polish oncological research centers. Oncology in Clinical Practice. 4(6). 232–244. 1 indexed citations
7.
Pietrzak, Lucyna, Krzysztof Bujko, Marek P. Nowacki, et al.. (2007). Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: Report of a randomised trial. Radiotherapy and Oncology. 84(3). 217–225. 123 indexed citations
8.
Bujko, Krzysztof, Wojciech Michalski, Lucyna Kępka, et al.. (2006). Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial. International Journal of Radiation Oncology*Biology*Physics. 67(2). 369–377. 73 indexed citations
9.
Reguła, Jarosław, Maciej Rupiński, Ewa Kraszewska, et al.. (2006). Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia. New England Journal of Medicine. 355(18). 1863–1872. 579 indexed citations breakdown →
10.
Bujko, Krzysztof, et al.. (2006). Abdominoperineal resection or anterior resection for rectal cancer: patient preferences before and after treatment. Colorectal Disease. 8(7). 575–580. 38 indexed citations
11.
Chmielik, Ewa, Krzysztof Bujko, Anna Nasierowska‐Guttmejer, et al.. (2006). Distal intramural spread of rectal cancer after preoperative radiotherapy: The results of a multicenter randomized clinical study. International Journal of Radiation Oncology*Biology*Physics. 65(1). 182–188. 33 indexed citations
12.
Bujko, Krzysztof, Marek P. Nowacki, Lucyna Kępka, et al.. (2005). Postoperative complications in patients irradiated pre‐operatively for rectal cancer: report of a randomised trial comparing short‐term radiotherapy vs chemoradiation. Colorectal Disease. 7(4). 410–416. 65 indexed citations
13.
Bujko, Krzysztof, Marek P. Nowacki, Anna Nasierowska‐Guttmejer, et al.. (2005). Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial. Implication for subsequent local excision. Radiotherapy and Oncology. 76(3). 234–240. 71 indexed citations
14.
Kamińska, Janina, Marek P. Nowacki, M Kowalska, et al.. (2005). Clinical Significance of Serum Cytokine Measurements in Untreated Colorectal Cancer Patients: Soluble Tumor Necrosis Factor Receptor Type I – An Independent Prognostic Factor. Tumor Biology. 26(4). 186–194. 93 indexed citations
15.
Bujko, Krzysztof, Marek P. Nowacki, Anna Nasierowska‐Guttmejer, et al.. (2004). Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiotherapy and Oncology. 72(1). 15–24. 355 indexed citations
16.
Nowacki, Marek P., Andrzej Rutkowski, Janusz Olędzki, & Maciej Chwaliński. (2004). Prospective, randomized trial examining the role of gentamycin-containing collagen sponge in the reduction of postoperative morbidity in rectal cancer patients: early results and surprising outcome at 3-year follow-up. International Journal of Colorectal Disease. 20(2). 114–120. 29 indexed citations
17.
Bujko, Krzysztof & Marek P. Nowacki. (2002). Emerging standards of radiotherapy combined with radical rectal cancer surgery. Cancer Treatment Reviews. 28(2). 101–113. 4 indexed citations
18.
Chwaliński, Maciej, Marek P. Nowacki, & Anna Nasierowska‐Guttmejer. (2001). Anorectal teratoma in an adult woman. International Journal of Colorectal Disease. 16(6). 398–401. 4 indexed citations
19.
Kamińska, Janina, et al.. (2000). CRP, TNFα, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients. Pathology & Oncology Research. 6(1). 38–41. 49 indexed citations
20.
Bujko, Krzysztof, et al.. (1998). Radiation Therapy for Anorectal Melanoma: A Report of Three Cases. Acta Oncologica. 37(5). 497–499. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐François Seitz Breakdown of academic impact, for papers by Jorge Aparicio Breakdown of academic impact, for papers by Arnaud Roth Breakdown of academic impact, for papers by Yong Sang Hong Breakdown of academic impact, for papers by R.D. James Breakdown of academic impact, for papers by Florin Sirzén Breakdown of academic impact, for papers by J. Załuski Breakdown of academic impact, for papers by Cynthia G. Leichman Breakdown of academic impact, for papers by Woo Yong Lee Breakdown of academic impact, for papers by Gérard Lledo
Rankless by CCL
2026